Discover
APUS
Apimeds Pharmaceuticals US, Inc.
5.02
700 x 6.41
100 x 6.13
bid
ask
-
0.49
8.89%
400 @ 07:59 PM
6.11 +1.09 (21.71%)
| Ytd | -69.39% | |
| 1y | -73.01% |
4.40
day range
5.70
1.60
52 week range
38.95
| Open | 5.54 | Prev Close | 5.51 | Low | 4.40 | High | 5.70 | Mkt Cap | 7.58M |
| Vol | 3.35M | Avg Vol | 3.67M | EPS | -32.83 | P/E | N/A | Forward P/E | N/A |
| Beta | -0.37 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 3.98 | 200-d Avg | 11.98 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 6.28M | ||
| Research and Development Expense | 959.74K | ||
| Selling, General and Administrative Expense | 5.32M | ||
| Operating Income | -6.28M | ||
| Interest Expense | 3.22M | ||
| Net Income | -20.17M | ||
| Net Income Common Stock | -20.17M | ||
| Net Income Common Stock (USD) | -20.17M | ||
| Consolidated Income | -20.17M | ||
| Earnings per Basic Share | -11.77 | ||
| Earnings per Basic Share (USD) | -11.77 | ||
| Earnings per Diluted Share | -11.77 | ||
| Earning Before Interest & Taxes (EBIT) | -16.95M | ||
| Earning Before Interest & Taxes (USD) | -16.95M | ||
| Weighted Average Shares | 1.71M | ||
| Weighted Average Shares Diluted | 1.71M | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.28M | ||
| Cash and Equivalents (USD) | 8.28M | ||
| Investments | 116.74M | ||
| Investments Non-Current | 116.74M | ||
| Trade and Non-Trade Receivables | 115.57K | ||
| Current Assets | 10.68M | ||
| Property, Plant & Equipment Net | 208.09K | ||
| Total Assets | 127.62M | ||
| Debt Current | 14.48M | ||
| Total Debt | 14.58M | ||
| Current Liabilities | 21.07M | ||
| Debt Non-Current | 101.87K | ||
| Total Liabilities | 21.18M | ||
| Accumulated Retained Earnings (Deficit) | -65.63M | ||
| Shareholders Equity | 106.45M | ||
| Shareholders Equity (USD) | 106.45M | ||
| Assets Non-Current | 116.95M | ||
| Total Debt (USD) | 14.58M | ||
| Liabilities Non-Current | 101.87K | ||
| Trade and Non-Trade Payables | 3.22M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 20.28K | ||
| Net Cash Flow from Financing | 3.47M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -701.16K | ||
| Issuance (Repayment) of Debt Securities | 3.39M | ||
| Net Cash Flow from Investing | 1.50M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 1.50M | ||
| Net Cash Flow from Operations | -5.67M | ||
| Share Based Compensation | 105.21K | ||